Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Clinical and Experimental Emergency Medicine is Scopus-indexed (Q2, CiteScore 3.5), WoS ESCI, DOAJ. Published by Korean Society of Emergency Medicine.
Checked against the index lists dated .
ISSN 2383-4625Verify ISSN ↗
Publisher: Korean Society of Emergency Medicine
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Emergency Medicine | 29 / 111 | 74th | Q2 |
| Emergency Nursing | 9 / 31 | 72nd | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2018–present, best quartile Q2, CiteScore 3.5.
Clinical and Experimental Emergency Medicine is Q2 in Emergency Medicine (rank 29 of 111) and Q2 in Emergency Nursing (rank 9 of 31), by CiteScore 2025.
Clinical and Experimental Emergency Medicine is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3.5, which places it in quartile Q2 at the 74th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.523, quartile Q2, with an H-index of 23.
Clinical and Experimental Emergency Medicine is published by Korean Society of Emergency Medicine. Its ISSN is 2383-4625.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Clinical and Experimental Emergency Medicine has an h-index of 37 and a 2-year mean of 1.85 citations per paper (OpenAlex). Its Scopus CiteScore is 3.5, quartile Q2. On 2-year citations it ranks #21 of 109 Scopus journals in Emergency Medicine.
Clinical and Experimental Emergency Medicine published 51 papers in 2025; its busiest recent year was 2023 with 78. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 97 research articles (2025–2026), authors are most often from South Korea (40.2%), United States (22.2%) and Japan (6.2%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.